Heart Test Laboratories (HSCS) Competitors $3.10 -0.12 (-3.73%) As of 01:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock HSCS vs. NRXS, ICU, SSKN, CODX, POAI, PAVM, INBS, DHAI, NURO, and BSGMShould you be buying Heart Test Laboratories stock or one of its competitors? The main competitors of Heart Test Laboratories include NeurAxis (NRXS), SeaStar Medical (ICU), STRATA Skin Sciences (SSKN), Co-Diagnostics (CODX), Predictive Oncology (POAI), PAVmed (PAVM), Intelligent Bio Solutions (INBS), DIH Holding US (DHAI), NeuroMetrix (NURO), and BioSig Technologies (BSGM). These companies are all part of the "medical equipment" industry. Heart Test Laboratories vs. NeurAxis SeaStar Medical STRATA Skin Sciences Co-Diagnostics Predictive Oncology PAVmed Intelligent Bio Solutions DIH Holding US NeuroMetrix BioSig Technologies Heart Test Laboratories (NASDAQ:HSCS) and NeurAxis (NASDAQ:NRXS) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, community ranking, media sentiment, institutional ownership, risk, valuation, profitability and dividends. Do insiders and institutionals believe in HSCS or NRXS? 17.2% of Heart Test Laboratories shares are held by institutional investors. Comparatively, 11.8% of NeurAxis shares are held by institutional investors. 1.8% of Heart Test Laboratories shares are held by insiders. Comparatively, 15.2% of NeurAxis shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more volatility & risk, HSCS or NRXS? Heart Test Laboratories has a beta of 2.71, indicating that its share price is 171% more volatile than the S&P 500. Comparatively, NeurAxis has a beta of 3.46, indicating that its share price is 246% more volatile than the S&P 500. Do analysts rate HSCS or NRXS? Heart Test Laboratories currently has a consensus price target of $13.00, indicating a potential upside of 319.35%. Given Heart Test Laboratories' stronger consensus rating and higher probable upside, research analysts clearly believe Heart Test Laboratories is more favorable than NeurAxis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Heart Test Laboratories 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00NeurAxis 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is HSCS or NRXS more profitable? Heart Test Laboratories has a net margin of 0.00% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat Heart Test Laboratories' return on equity.Company Net Margins Return on Equity Return on Assets Heart Test LaboratoriesN/A -117.76% -84.09% NeurAxis -492.76%N/A -641.25% Does the media prefer HSCS or NRXS? In the previous week, Heart Test Laboratories had 1 more articles in the media than NeurAxis. MarketBeat recorded 1 mentions for Heart Test Laboratories and 0 mentions for NeurAxis. Heart Test Laboratories' average media sentiment score of 1.89 beat NeurAxis' score of 0.00 indicating that Heart Test Laboratories is being referred to more favorably in the media. Company Overall Sentiment Heart Test Laboratories Very Positive NeurAxis Neutral Does the MarketBeat Community believe in HSCS or NRXS? Heart Test Laboratories received 5 more outperform votes than NeurAxis when rated by MarketBeat users. However, 100.00% of users gave NeurAxis an outperform vote while only 85.71% of users gave Heart Test Laboratories an outperform vote. CompanyUnderperformOutperformHeart Test LaboratoriesOutperform Votes685.71% Underperform Votes114.29%NeurAxisOutperform Votes1100.00% Underperform VotesNo Votes Which has higher valuation & earnings, HSCS or NRXS? Heart Test Laboratories has higher earnings, but lower revenue than NeurAxis. NeurAxis is trading at a lower price-to-earnings ratio than Heart Test Laboratories, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHeart Test Laboratories$14.70K227.97-$6.61M-$7.48-0.41NeurAxis$2.69M4.31-$14.63M-$1.20-1.34 SummaryHeart Test Laboratories beats NeurAxis on 12 of the 18 factors compared between the two stocks. Remove Ads Get Heart Test Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for HSCS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSCS vs. The Competition Export to ExcelMetricHeart Test LaboratoriesSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.35M$8.64B$5.32B$7.42BDividend YieldN/A1.71%5.11%4.32%P/E Ratio-0.3918.6021.7317.75Price / Sales227.9770.42372.3693.57Price / CashN/A19.6738.1534.64Price / Book0.284.786.393.97Net Income-$6.61M$284.66M$3.20B$247.37M7 Day Performance-0.80%-0.29%2.11%1.02%1 Month Performance6.49%-2.50%-9.13%-6.65%1 Year Performance-70.19%-22.00%9.92%0.06% Heart Test Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSCSHeart Test Laboratories2.8425 of 5 stars$3.10-3.7%$13.00+319.4%-68.6%$3.35M$14,700.00-0.3910Positive NewsGap DownNRXSNeurAxisN/A$1.71-7.8%N/A-44.3%$12.30M$2.69M-0.9319ICUSeaStar Medical0.1197 of 5 stars$1.35+0.4%N/A-92.2%$11.86M$135,000.00-0.122Short Interest ↑Gap UpSSKNSTRATA Skin Sciences3.1119 of 5 stars$2.63+1.4%$6.00+128.6%-44.2%$11.60M$33.56M-1.05120Positive NewsCODXCo-Diagnostics4.0873 of 5 stars$0.33+5.3%$1.00+205.8%-70.3%$11.05M$3.92M-0.24100Short Interest ↓Gap DownPOAIPredictive Oncology1.684 of 5 stars$1.16+4.1%$3.00+159.7%-35.3%$10.36M$1.62M-0.3830Short Interest ↑Gap UpPAVMPAVmed3.9748 of 5 stars$0.59-1.7%$19.00+3,120.3%-62.5%$10.02M$3.00M-0.1490Short Interest ↑INBSIntelligent Bio Solutions0.2501 of 5 stars$1.38+4.2%N/A-61.3%$9.40M$3.03M0.0010Short Interest ↑Gap DownDHAIDIH Holding US1.1328 of 5 stars$0.19+4.4%N/A-86.0%$9.28M$64.47M-0.65N/ANews CoverageGap DownNURONeuroMetrix1.0975 of 5 stars$4.45+0.8%N/A+23.5%$9.16M$3.03M-0.9720Analyst ForecastShort Interest ↓BSGMBioSig Technologies1.9151 of 5 stars$0.52flat$2.75+434.0%-46.4%$8.88M$39,000.000.0050Gap Down Remove Ads Related Companies and Tools Related Companies NeurAxis Competitors SeaStar Medical Competitors STRATA Skin Sciences Competitors Co-Diagnostics Competitors Predictive Oncology Competitors PAVmed Competitors Intelligent Bio Solutions Competitors DIH Holding US Competitors NeuroMetrix Competitors BioSig Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSCS) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heart Test Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heart Test Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
